Status:
UNKNOWN
Symprove (Probiotic) as an add-on to COVID-19 Management
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Covid19
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The major impact of COVID-19 has been that the severity of respiratory symptoms require intensive hospital treatment. There is significant mortality and many of the survivors have a delayed recovery r...
Eligibility Criteria
Inclusion
- Symptomatic patients who are hospitalised with respiratory COVID-19
- Ability to give informed consent
- Aged 20-85
Exclusion
- Patients not meeting the inclusion criteria that have COVID-19
- Inability to consent
- Pregnancy
- Severe pre-existing mental health disorders or addictions
Key Trial Info
Start Date :
May 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04877704
Start Date
May 31 2021
End Date
April 30 2022
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver Studies
London, United Kingdom, SE5 9RS